[
  {
    "ts": "2026-02-05T10:11:08+00:00",
    "headline": "A Look At IQVIA Holdings (IQV) Valuation After Recent Share Price Volatility",
    "summary": "IQVIA Holdings (IQV) has been drawing attention after a period of weaker share performance, with the stock down around 14% over the past month and about 4% over the past 3 months. See our latest analysis for IQVIA Holdings. At a share price of US$202.54, IQVIA’s recent 7 day share price return of 15.52% and 30 day share price return of 13.66% sit against a year to date share price return of 10.13%, while the 1 year total shareholder return of 1.41% and 3 year total shareholder return of...",
    "url": "https://finance.yahoo.com/news/look-iqvia-holdings-iqv-valuation-101108733.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "a0b21067-c174-330d-b441-db76e55b8f41",
      "content": {
        "id": "a0b21067-c174-330d-b441-db76e55b8f41",
        "contentType": "STORY",
        "title": "A Look At IQVIA Holdings (IQV) Valuation After Recent Share Price Volatility",
        "description": "",
        "summary": "IQVIA Holdings (IQV) has been drawing attention after a period of weaker share performance, with the stock down around 14% over the past month and about 4% over the past 3 months. See our latest analysis for IQVIA Holdings. At a share price of US$202.54, IQVIA’s recent 7 day share price return of 15.52% and 30 day share price return of 13.66% sit against a year to date share price return of 10.13%, while the 1 year total shareholder return of 1.41% and 3 year total shareholder return of...",
        "pubDate": "2026-02-05T10:11:08Z",
        "displayTime": "2026-02-05T10:11:08Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/aa699fbfacb1e146d6b73dd53e729fbb",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6nKISX1GLRwu7E4Xp7LSxg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/aa699fbfacb1e146d6b73dd53e729fbb.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cvUO2OUb4QTTAI.SWmf2EA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/aa699fbfacb1e146d6b73dd53e729fbb.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/look-iqvia-holdings-iqv-valuation-101108733.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/look-iqvia-holdings-iqv-valuation-101108733.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IQV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T12:36:12+00:00",
    "headline": "IQVIA’s (NYSE:IQV) Q4 CY2025 Sales Top Estimates",
    "summary": "Clinical research company IQVIA (NYSE: IQV) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 10.3% year on year to $4.36 billion. The company’s full-year revenue guidance of $17.25 billion at the midpoint came in 1% above analysts’ estimates. Its non-GAAP profit of $3.42 per share was 0.7% above analysts’ consensus estimates.",
    "url": "https://finance.yahoo.com/news/iqvia-nyse-iqv-q4-cy2025-123612663.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "d4b24a23-b937-3a0e-87ba-416216481604",
      "content": {
        "id": "d4b24a23-b937-3a0e-87ba-416216481604",
        "contentType": "STORY",
        "title": "IQVIA’s (NYSE:IQV) Q4 CY2025 Sales Top Estimates",
        "description": "",
        "summary": "Clinical research company IQVIA (NYSE: IQV) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 10.3% year on year to $4.36 billion. The company’s full-year revenue guidance of $17.25 billion at the midpoint came in 1% above analysts’ estimates. Its non-GAAP profit of $3.42 per share was 0.7% above analysts’ consensus estimates.",
        "pubDate": "2026-02-05T12:36:12Z",
        "displayTime": "2026-02-05T12:36:12Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/24070549d076ed63ce3e30be97c1f359",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "IQV Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/T63.FuKezMn3IfaDQpt3fA--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/24070549d076ed63ce3e30be97c1f359.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/05OLjRFBrGdNmOrY1wbEDA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/24070549d076ed63ce3e30be97c1f359.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/iqvia-nyse-iqv-q4-cy2025-123612663.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/iqvia-nyse-iqv-q4-cy2025-123612663.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IQV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T12:20:46+00:00",
    "headline": "IQVIA: Q4 Earnings Snapshot",
    "summary": "The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of $3.40 per share. The clinical testing company posted revenue of $4.36 billion in the period, also beating Street forecasts. Eight analysts surveyed by Zacks expected $4.24 billion.",
    "url": "https://finance.yahoo.com/news/iqvia-q4-earnings-snapshot-122046487.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "044bbe91-035c-31c7-876c-7ecd9d915670",
      "content": {
        "id": "044bbe91-035c-31c7-876c-7ecd9d915670",
        "contentType": "STORY",
        "title": "IQVIA: Q4 Earnings Snapshot",
        "description": "",
        "summary": "The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of $3.40 per share. The clinical testing company posted revenue of $4.36 billion in the period, also beating Street forecasts. Eight analysts surveyed by Zacks expected $4.24 billion.",
        "pubDate": "2026-02-05T12:20:46Z",
        "displayTime": "2026-02-05T12:20:46Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/iqvia-q4-earnings-snapshot-122046487.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/iqvia-q4-earnings-snapshot-122046487.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IQV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T14:07:14+00:00",
    "headline": "IQVIA forecasts weak annual profit on higher interest expenses",
    "summary": "Healthcare data and clinical research provider IQVIA Holdings on Thursday forecast annual profit below Wall Street expectations, weighed ​down by higher interest costs, even as strong fourth-quarter results underscored ‌improving demand from pharmaceutical clients. The results come amid persistent challenges facing contract research and analytics ‌companies, as cautious biotech funding and longer decision cycles continue in some markets. The company expects 2026 adjusted earnings in the range of $12.55 to $12.85 per share, falling far short of analysts' average estimate of $12.95 per share, according to LSEG ⁠data.",
    "url": "https://finance.yahoo.com/news/iqvia-forecasts-weak-annual-profit-140714120.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "319083b9-bc6c-325d-9d7e-db626d355ebf",
      "content": {
        "id": "319083b9-bc6c-325d-9d7e-db626d355ebf",
        "contentType": "STORY",
        "title": "IQVIA forecasts weak annual profit on higher interest expenses",
        "description": "",
        "summary": "Healthcare data and clinical research provider IQVIA Holdings on Thursday forecast annual profit below Wall Street expectations, weighed ​down by higher interest costs, even as strong fourth-quarter results underscored ‌improving demand from pharmaceutical clients. The results come amid persistent challenges facing contract research and analytics ‌companies, as cautious biotech funding and longer decision cycles continue in some markets. The company expects 2026 adjusted earnings in the range of $12.55 to $12.85 per share, falling far short of analysts' average estimate of $12.95 per share, according to LSEG ⁠data.",
        "pubDate": "2026-02-05T14:07:14Z",
        "displayTime": "2026-02-05T14:07:14Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Reuters",
          "url": "http://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/iqvia-forecasts-weak-annual-profit-140714120.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/iqvia-forecasts-weak-annual-profit-140714120.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IQV"
            },
            {
              "symbol": "TMO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T13:15:02+00:00",
    "headline": "IQVIA Holdings (IQV) Q4 Earnings and Revenues Top Estimates",
    "summary": "IQVIA (IQV) delivered earnings and revenue surprises of +0.50% and +2.83%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finance.yahoo.com/news/iqvia-holdings-iqv-q4-earnings-131502106.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "476b975c-2622-33ec-97ce-12bba03ccd91",
      "content": {
        "id": "476b975c-2622-33ec-97ce-12bba03ccd91",
        "contentType": "STORY",
        "title": "IQVIA Holdings (IQV) Q4 Earnings and Revenues Top Estimates",
        "description": "",
        "summary": "IQVIA (IQV) delivered earnings and revenue surprises of +0.50% and +2.83%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?",
        "pubDate": "2026-02-05T13:15:02Z",
        "displayTime": "2026-02-05T13:15:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/b9775f315e7b6c4ada6e36d0048a929a",
          "originalWidth": 900,
          "originalHeight": 728,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qda7CGFBlQ8XGALeSrKgqg--~B/aD03Mjg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b9775f315e7b6c4ada6e36d0048a929a.cf.webp",
              "width": 900,
              "height": 728,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4xjRGdTikgXo5SMeFUiNTA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b9775f315e7b6c4ada6e36d0048a929a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/iqvia-holdings-iqv-q4-earnings-131502106.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/iqvia-holdings-iqv-q4-earnings-131502106.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IQV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T16:55:53+00:00",
    "headline": "IQVIA (IQV) Stock Trades Down, Here Is Why",
    "summary": "Shares of clinical research company IQVIA (NYSE: IQV) fell 8.5% in the morning session after the company issued a weak full-year 2026 profit forecast that fell below Wall Street expectations.",
    "url": "https://finance.yahoo.com/news/iqvia-iqv-stock-trades-down-165553218.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "77667f2e-8d27-3064-9c3f-b8abc36f4469",
      "content": {
        "id": "77667f2e-8d27-3064-9c3f-b8abc36f4469",
        "contentType": "STORY",
        "title": "IQVIA (IQV) Stock Trades Down, Here Is Why",
        "description": "",
        "summary": "Shares of clinical research company IQVIA (NYSE: IQV) fell 8.5% in the morning session after the company issued a weak full-year 2026 profit forecast that fell below Wall Street expectations.",
        "pubDate": "2026-02-05T16:55:53Z",
        "displayTime": "2026-02-05T16:55:53Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/24070549d076ed63ce3e30be97c1f359",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "IQV Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/T63.FuKezMn3IfaDQpt3fA--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/24070549d076ed63ce3e30be97c1f359.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/05OLjRFBrGdNmOrY1wbEDA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/24070549d076ed63ce3e30be97c1f359.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/iqvia-iqv-stock-trades-down-165553218.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/iqvia-iqv-stock-trades-down-165553218.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IQV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T14:07:14+00:00",
    "headline": "IQVIA backs AI strategy as analysts question impact on business",
    "summary": "Healthcare data and clinical research provider IQVIA Holdings on Thursday defended its AI strategy against analyst ​concerns that recent technology advances could displace the company's services, after it ‌forecast annual profit below Wall Street expectations. The questions, posed during an earnings call, came after a six-day ‌selloff wiped out nearly $830 billion in market value from software and services stocks, triggered by new AI tools from companies like Anthropic that are increasingly competing with established enterprise businesses. Shares of IQVIA fell over 8% in late morning trading.",
    "url": "https://finance.yahoo.com/news/iqvia-forecasts-weak-annual-profit-140714120.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "319083b9-bc6c-325d-9d7e-db626d355ebf",
      "content": {
        "id": "319083b9-bc6c-325d-9d7e-db626d355ebf",
        "contentType": "STORY",
        "title": "IQVIA backs AI strategy as analysts question impact on business",
        "description": "",
        "summary": "Healthcare data and clinical research provider IQVIA Holdings on Thursday defended its AI strategy against analyst ​concerns that recent technology advances could displace the company's services, after it ‌forecast annual profit below Wall Street expectations. The questions, posed during an earnings call, came after a six-day ‌selloff wiped out nearly $830 billion in market value from software and services stocks, triggered by new AI tools from companies like Anthropic that are increasingly competing with established enterprise businesses. Shares of IQVIA fell over 8% in late morning trading.",
        "pubDate": "2026-02-05T14:07:14Z",
        "displayTime": "2026-02-05T14:07:14Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Reuters",
          "url": "http://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/iqvia-forecasts-weak-annual-profit-140714120.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/iqvia-forecasts-weak-annual-profit-140714120.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IQV"
            },
            {
              "symbol": "ANTH.PVT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T14:07:14+00:00",
    "headline": "IQVIA forecasts weak annual profit on higher interest expenses",
    "summary": "Feb 5 (Reuters) - Healthcare data and clinical research provider IQVIA Holdings on Thursday forecast annual profit below Wall Street expectations, weighed down by higher interest costs, even as strong",
    "url": "https://finance.yahoo.com/news/iqvia-forecasts-weak-annual-profit-140714005.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "b6683cd6-56d2-3fe7-a867-fd405acd3e64",
      "content": {
        "id": "b6683cd6-56d2-3fe7-a867-fd405acd3e64",
        "contentType": "STORY",
        "title": "IQVIA forecasts weak annual profit on higher interest expenses",
        "description": "",
        "summary": "Feb 5 (Reuters) - Healthcare data and clinical research provider IQVIA Holdings on Thursday forecast annual profit below Wall Street expectations, weighed down by higher interest costs, even as strong",
        "pubDate": "2026-02-05T14:07:14Z",
        "displayTime": "2026-02-05T14:07:14Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/iqvia-forecasts-weak-annual-profit-140714005.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/iqvia-forecasts-weak-annual-profit-140714005.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IQV"
            },
            {
              "symbol": "TMO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T17:11:00+00:00",
    "headline": "IQVIA Q4 Earnings & Revenues Beat Estimates, Increase Y/Y",
    "summary": "IQV posted a fourth-quarter 2025 earnings and revenue beat with double-digit Y/Y sales growth, strong segment gains and upbeat 2026 revenue guidance.",
    "url": "https://finance.yahoo.com/news/iqvia-q4-earnings-revenues-beat-171100379.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "e320627d-1c72-3774-8992-5c66d034fb43",
      "content": {
        "id": "e320627d-1c72-3774-8992-5c66d034fb43",
        "contentType": "STORY",
        "title": "IQVIA Q4 Earnings & Revenues Beat Estimates, Increase Y/Y",
        "description": "",
        "summary": "IQV posted a fourth-quarter 2025 earnings and revenue beat with double-digit Y/Y sales growth, strong segment gains and upbeat 2026 revenue guidance.",
        "pubDate": "2026-02-05T17:11:00Z",
        "displayTime": "2026-02-05T17:11:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EzN04L.MG5n2SiOn76bXjg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1EIdoTL1xBchT1nrSboC2Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/iqvia-q4-earnings-revenues-beat-171100379.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/iqvia-q4-earnings-revenues-beat-171100379.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IQV"
            },
            {
              "symbol": "EFX"
            },
            {
              "symbol": "IT"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T21:00:58+00:00",
    "headline": "IQVIA Holdings Inc (IQV) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...",
    "summary": "IQVIA Holdings Inc (IQV) reports robust fourth-quarter performance with a 10.3% revenue increase and strategic advancements in AI and cloud technologies.",
    "url": "https://finance.yahoo.com/news/iqvia-holdings-inc-iqv-q4-210058395.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "0017ece6-f918-309d-9105-a7fb25116151",
      "content": {
        "id": "0017ece6-f918-309d-9105-a7fb25116151",
        "contentType": "STORY",
        "title": "IQVIA Holdings Inc (IQV) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...",
        "description": "",
        "summary": "IQVIA Holdings Inc (IQV) reports robust fourth-quarter performance with a 10.3% revenue increase and strategic advancements in AI and cloud technologies.",
        "pubDate": "2026-02-05T21:00:58Z",
        "displayTime": "2026-02-05T21:00:58Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/iqvia-holdings-inc-iqv-q4-210058395.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/iqvia-holdings-inc-iqv-q4-210058395.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IQV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]